74 beste Ärzte für Ösophagektomie

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Mit Spezialisierung auf Leber- und Verdauungsgesundheit bringt Nurana Guliyeva fundierte Expertise für komplexe Magen-Darm-Erkrankungen in das Biological Medicine - Integrative Health Center in Baku ein.

• Über ein Jahrzehnt Erfahrung in Gastroenterologie und Hepatologie
• Ausgebildet an der Ege-Universität und dem Ankara Hacettepe Krankenhaus in der Türkei
• Spezialisiert auf die Behandlung von viraler Hepatitis und Autoimmunerkrankungen der Leber
• Bietet integrative Ansätze, die biologische Medizin mit konventionellen Behandlungen kombinieren

Volkan Kinas ist auf komplexe gastrointestinale und onkologische Operationen in den Büyük Anadolu Krankenhäusern spezialisiert.

• Experte für Magenkrebs-, Darmkrebs- und Bauchspeicheldrüsenoperationen
• Ausgebildet in onkologischen und bariatrischen Stoffwechselverfahren
• Führt nach Möglichkeit minimalinvasive Techniken durch

Dr. Yilmaz Bilgic verfügt über spezialisierte Expertise in der Gastroenterologie mit fortgeschrittener Ausbildung in endoskopischen Verfahren.

• Dozent für Gastroenterologie seit 2018
• Fortgeschrittene Endoskopie-Ausbildung in Südkorea und Deutschland
• Spezialisiert auf Innere Medizin und Gastroenterologie
• Veröffentlichte Forschungsergebnisse zur Leberregeneration und verwandten Bereichen

Prof. Cemalettin Aydin ist auf Ösophagektomie-Eingriffe im Medipol Acibadem District Hospital spezialisiert.

• Stipendium für Gastroenterologie-Chirurgie vom Türkiye High Specialization Hospital
• Über _doctor_7666_ Jahre Erfahrung in der Allgemeinchirurgie
• Volle Professur für Allgemeinchirurgie an der İnönü-Universität
• Ausbildung am Ankara Numune Training and Research Hospital

Spezialisiert auf minimalinvasive Ösophagektomie – Dr. Aktas führt seit 1995 fortgeschrittene laparoskopische Eingriffe durch und wurde in Deutschland ausgebildet.

• _doctor_9186_Jahre_ Erfahrung in der Allgemeinchirurgie mit Schwerpunkt Onkologie
• Experte für komplexe Magen-Darm-Tumoroperationen
• Pionier moderner Techniken in der Krebs- und Stoffwechselchirurgie
• Leiter chirurgischer Abteilungen in mehreren Militärkrankenhäusern

Der Fachchirurg Dr. Rafail Ibayev führt im Erdem Hospital ein breites Spektrum an laparoskopischen und offenen Magen-Darm-Eingriffen durch.

• Experte für Magenoperationen bei bösartigen und gutartigen Erkrankungen
• Erfahren in der Leberchirurgie und komplexen Darmeingriffen
• Führt onkoplastische Brustoperationen und Schilddrüsenoperationen durch
• Erfahren in endoskopischen Verfahren wie Gastroskopie und Koloskopie

Spezialisiert auf komplexe Magenkrebsoperationen – Dr. Tarkan bringt fokussierte Expertise bei Ösophagektomie-Fällen in die Klinik Mavi ein.

• Mitglied der Türkischen Gesellschaft für Adipositaschirurgie
• Mitglied der International Federation for the Surgery of Obesity
• Absolvent der medizinischen Fakultät der Universität Dicle

_doctor_2245_Jahre_ Erfahrung in der Chirurgie des oberen Gastrointestinaltrakts und der Adipositaschirurgie – Dr. Palep ist ein Pionier bei minimalinvasiven Techniken.

• Ausgebildet in robotischer GI-Chirurgie in Italien für präzise und schnellere Genesung
• Führt fortschrittliche minimalinvasive und robotische Operationen am oberen GI-Trakt durch
• Veröffentlichte zahlreiche begutachtete Artikel in internationalen Fachzeitschriften
• Eingeladener Redner auf nationalen und internationalen Konferenzen

Dr. Ayman ist auf minimalinvasive Ösophagektomie spezialisiert und verfügt über eine fortgeschrittene Ausbildung an führenden Einrichtungen in Italien und Belgien.

• _doctor_8606_Jahre_ Erfahrung in der Allgemein- und Adipositaschirurgie
• Experte für Magen- und Kolorektalchirurgie, einschließlich komplexer Eingriffe
• Mitglied der IFSO, trägt zur internationalen Weiterentwicklung der Adipositaschirurgie bei
• Praktiziert im Maria Cecilia Hospital, bekannt für das Management komplexer Patienten

Spezialisiert auf Gastroenterologie mit umfassender Ausbildung und Führungspositionen an führenden türkischen Krankenhäusern. Doz. Dr. Ozturk bringt fundierte Expertise in komplexe gastrointestinale Eingriffe ein.

• Zertifizierter Gastroenterologe mit über 13 Jahren Erfahrung
• Ehemaliger leitender Assistent der Gastroenterologie-Klinik am Ümraniye Ausbildungs- und Forschungskrankenhaus
• Mitglied der Türkischen Gesellschaft für Gastroenterologie und der Gesellschaft für Gastrointestinale Endoskopie
• Preisgekrönter Forscher in der Gastroenterologie

Dozentin Meryem Keceli Basaran ist auf pädiatrische Gastroenterologie am Istinye University Medicalpark Gaziosmanpaşa Krankenhaus spezialisiert.

• Subspezialistin für pädiatrische Gastroenterologie mit langjähriger klinischer Erfahrung
• Expertin für Reizdarmsyndrom und Nahrungsmittelallergien im Zusammenhang mit dem Verdauungssystem
• Mitglied der ESPGHAN - European Society for Pediatric Gastroenterology Hepatology and Nutrition
• Behandelt komplexe Fälle wie chronische Bauchschmerzen und Morbus Crohn

Dr. Ahmer Arif Shaikh ist auf Mundhöhlenkrebs und funktionelle Rehabilitation spezialisiert, wobei der Schwerpunkt auf dem Erhalt von Organen und der Verbesserung der Patientenergebnisse liegt.

• 15 Jahre Erfahrung in der chirurgischen Onkologie
• Expertise bei großen kieferchirurgischen Eingriffen sowie Kopf- und Halsoperationen
• Fellowship-ausgebildet in der chirurgischen Onkologie von Kopf und Hals
• Forscher mit zahlreichen Publikationen

Dr. Gunluoglu ist auf Thoraxchirurgie spezialisiert und konzentriert sich auf komplexe Speiseröhreneingriffe am Medipol Mega University Hospital.

• Spezialisiert auf Ösophagektomie und damit verbundene Thoraxoperationen
• Praktiziert an einem führenden Universitätskrankenhaus in der Türkei
• Experte für das postoperative Management nach Speiseröhrenoperationen

Prof. Dr. Abdullah Sakin ist Professor für Medizinische Onkologie. Er behandelt solide Tumoren, darunter Lungen-, Brust-, gastrointestinale, urogenitale, gynäkologische sowie Kopf-Hals-Tumoren und Melanome.

Er bietet personalisierte, evidenzbasierte Behandlung. Sein Behandlungsspektrum umfasst Chemotherapie, zielgerichtete Therapien, Immuntherapie, Hormontherapie und Präzisionsonkologie. Er ist Autor von über 200 wissenschaftlichen Publikationen und beteiligt sich an internationaler klinischer Forschung. Diese Arbeit treibt die patientenzentrierte Krebsversorgung voran.

Prof. Dr. Gül Alço ist Radioonkologin mit rund 27 Jahren Erfahrung. Sie behandelt mit Strahlentherapie Brust-, Lungen-, Prostata-, gastrointestinale und gynäkologische Karzinome sowie Tumoren des zentralen Nervensystems, des Kopf-Hals-Bereichs, der Weichteile und der Knochen.

Ihre Expertise umfasst adaptive Radiotherapie und Radiochirurgie. Sie setzt fortschrittliche Strahlentechniken ein, um in einem multidisziplinären, patientenzentrierten Umfeld eine personalisierte, evidenzbasierte Versorgung zu bieten.

Prof. Dr. İbrahim Doğan ist Gastroenterologe. Er erwarb 1991 seinen M.D. an der Medizinischen Fakultät der Universität Ankara. 1996 wurde er an der Gazi-Universität Facharzt für Innere Medizin. Die Schwerpunktweiterbildung Gastroenterologie schloss er 2001 an der İnönü-Universität ab.

Seine akademische Laufbahn verlief an der Gazi-Universität. Er war Dozent (2002), Assistenzprofessor (2003), außerordentlicher Professor (2007) und Professor (2012). Von 2004 bis 2006 forschte er an der University of California San Diego. Seit Januar 2023 praktiziert er am Koru-Krankenhaus.

Seine klinischen Schwerpunkte umfassen gastroösophagealen Reflux, Reizdarmsyndrom, Verstopfung, Gastroparese, Achalasie, Blähbauch, Flatulenz und Aufstoßen, Stuhlinkontinenz, Colitis ulcerosa und Morbus Crohn. Er führt ERCP, Stentimplantation, Ballon- und Bougiedilatation, Polypektomie, Argonplasmakoagulation, Doppelballon-Enteroskopie und Blutungsstillung durch.

I'm the Director of Clínica San Clemente and of the GenderMedic Unit, based in Zaragoza. I specialize in plastic, reconstructive and aesthetic surgery, performing breast surgery, facial and body procedures, hair restoration, and aesthetic medicine — the full spectrum of what a patient's journey may require, under one roof and one standard of care.

I trained through the MIR program at Hospital Universitario Miguel Servet in Zaragoza, and I'm a full member of the Spanish Society of Plastic, Aesthetic and Reconstructive Surgery (SECPRE) and of SUNRA. What I care about most isn't just the technical result — it's building a team capable of handling every case with the same rigor, whether it's a straightforward procedure or a complex, multidisciplinary journey.

That same commitment is why I founded Fundación Sigo Adelante, through which I personally perform reconstructive surgical missions in countries with limited medical access — because excellence should reach further than a clinic's walls. I lead the same standard of honesty, safety and personalized care at GenderMedic, where I coordinate a multidisciplinary team dedicated to gender affirmation.

Your wellbeing and your confidence in the results are, and will always be, my responsibility.

Dr. Osuská ist auf Gastroenterologie am Nationalen Krebsinstitut spezialisiert und konzentriert sich auf fortgeschrittene endoskopische Verfahren.

• Führt seit 2010 Endoskopien am Universitätsklinikum Nitra durch
• Mitglied der onkologischen Sektion der Slowakischen Gesellschaft für Gastroenterologie
• Schult andere Ärzte in endoskopischen Techniken
• Veröffentlicht Forschungsergebnisse in Fachzeitschriften und auf Konferenzen